ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,706.21
-0.35%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Fusion Pharmaceuticals Inc (FUSN)

  7. Fusion Pharmaceuticals Inc (FUSN) News

Fusion Pharmaceuticals (FUSN)

Fusion Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FUSN
DateTimeSourceHeadlineSymbolCompany
10/05/202421:15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FUSNFusion Pharmaceuticals Inc
10/05/202412:54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FUSNFusion Pharmaceuticals Inc
09/05/202421:14PR Newswire (US)Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate CancerNASDAQ:FUSNFusion Pharmaceuticals Inc
09/05/202421:14PR Newswire (Canada)Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate CancerNASDAQ:FUSNFusion Pharmaceuticals Inc
07/05/202413:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FUSNFusion Pharmaceuticals Inc
07/05/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FUSNFusion Pharmaceuticals Inc
07/05/202412:00PR Newswire (US)Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program UpdatesNASDAQ:FUSNFusion Pharmaceuticals Inc
07/05/202412:00PR Newswire (Canada)Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program UpdatesNASDAQ:FUSNFusion Pharmaceuticals Inc
26/04/202418:56PR Newswire (US)Kuehn Law Encourages HCP, IP, SLCA, and FUSN Investors to Contact Law FirmNASDAQ:FUSNFusion Pharmaceuticals Inc
25/04/202421:34PR Newswire (US)Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim OrderNASDAQ:FUSNFusion Pharmaceuticals Inc
25/04/202421:34PR Newswire (Canada)Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim OrderNASDAQ:FUSNFusion Pharmaceuticals Inc
09/04/202421:05PR Newswire (US)Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024NASDAQ:FUSNFusion Pharmaceuticals Inc
09/04/202421:05PR Newswire (Canada)Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024NASDAQ:FUSNFusion Pharmaceuticals Inc
20/03/202420:10PR Newswire (US)Kuehn Law Encourages DRQ, EVBG, FREE, and FUSN Investors to Contact Law FirmNASDAQ:FUSNFusion Pharmaceuticals Inc
20/03/202420:05PR Newswire (Canada)Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program UpdatesNASDAQ:FUSNFusion Pharmaceuticals Inc
20/03/202420:05PR Newswire (US)Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program UpdatesNASDAQ:FUSNFusion Pharmaceuticals Inc
19/03/202407:00PR Newswire (US)Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat CancerNASDAQ:FUSNFusion Pharmaceuticals Inc
19/03/202407:00PR Newswire (Canada)Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat CancerNASDAQ:FUSNFusion Pharmaceuticals Inc
06/03/202412:45PR Newswire (US)Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FUSNFusion Pharmaceuticals Inc
06/03/202412:45PR Newswire (Canada)Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FUSNFusion Pharmaceuticals Inc
05/03/202421:43PR Newswire (US)Fusion Pharmaceuticals to Present Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the 2024 AACR Annual MeetingNASDAQ:FUSNFusion Pharmaceuticals Inc
05/03/202421:43PR Newswire (Canada)Fusion Pharmaceuticals to Present Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the 2024 AACR Annual MeetingNASDAQ:FUSNFusion Pharmaceuticals Inc
26/02/202412:45PR Newswire (Canada)Fusion Pharmaceuticals to Present at Upcoming March Investor ConferencesNASDAQ:FUSNFusion Pharmaceuticals Inc
26/02/202412:45PR Newswire (US)Fusion Pharmaceuticals to Present at Upcoming March Investor ConferencesNASDAQ:FUSNFusion Pharmaceuticals Inc
16/02/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FUSNFusion Pharmaceuticals Inc
16/02/202413:45PR Newswire (US)Fusion Pharmaceuticals Enters into Exclusive Worldwide License Agreement with Heidelberg University and Euratom for Actinium-Based PSMA Targeted RadiotherapyNASDAQ:FUSNFusion Pharmaceuticals Inc
16/02/202413:45PR Newswire (Canada)Fusion Pharmaceuticals Enters into Exclusive Worldwide License Agreement with Heidelberg University and Euratom for Actinium-Based PSMA Targeted RadiotherapyNASDAQ:FUSNFusion Pharmaceuticals Inc
07/02/202412:45PR Newswire (Canada)Fusion Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:FUSNFusion Pharmaceuticals Inc
07/02/202412:45PR Newswire (US)Fusion Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:FUSNFusion Pharmaceuticals Inc
06/02/202421:45PR Newswire (Canada)Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FUSNFusion Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:FUSN

Your Recent History

COIN
BLFIETH
BlackFisk
EU
FLOW
Flow Traders
ASX
IPG
IPD
NYSE
TG
Tredegar
LSE
OSX5
Soue Mak Djes50
COIN
LIFUSD
Winding Tree
NYSE
IDT
IDT
COIN
INFTETH
InfinitusTokens
DGFX
DOGOUSDT
DogemonGo
LSE
83BV
Natwest.m 25
TSX
BDT
Bird Construction
COIN
ZHEGICUSD
zHEGIC
EU
BLEE
Bleecker
BIT
F28141
Vontobel Financial Produ...
TSXV
SBD
LSE
77DM
Euro.bk. 25
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved